2Davis M, Espiner E,Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea[J]. Lancet,1994, 343 (8895) :440-444.
3Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002,347 (3):161- 167.
4Lee SC,Stevens TL,Sandberg SM, et al. The potential of brain natriurefic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure[J].J Card Fail 2002,8(3) .149-154.
6Ono M, Tanabe K, Asanuma T, et al. Doppler echocardiographyderived index of myocardial performance (TEI index): comparison with brain natriuretic peptide levels in various heart disease[J]. Jpn Circ J, 2001,65(7) :637-642.
2[1]LISY O, LAINCHBURY J G, LESKINEN H, et al.Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure [J].Hypertension,2001,37(4):1089-1094.
3[2]NISHIKIMI T, YOSHIHARA F, MORIMOTO A, et al.Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension [J].Hypertension,1996,28(1):22-30.
4[3]NAKAYAMA T, SOMA M, TAKAHASHI Y, et al. Functional deletion mutation of the 5'-flanking region of type a human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese [J].Circulation Research,2000,86(8): 841-845.
5[4]NUMATA Y, BURNETT J C, JOUGASAKI M, et al.Immuniradiometric assay for the N-terminal fragment of proatrial natriuretic peptidein human plasma [J].Clin Chem,1998,44(5):1008-1013.
6[5]SUO M, HAUTALA N, FLDES G, et al. Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension [J]. Hypertension,2002,39(3):803-808.
7[6]HARSHFIELD G A, TREIBER F A, DAVIS H,et al. Impaired stress-induced pressure natriuresis is related to left ventricle structure in blacks [J].Hypertension,2002,39(4):844-847.
8[7]NANNIPIERI M, MANGANIELLO M, PEZZATINI A,et al.Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension [J]. Hypertension, 2001,37(6):1416-1422.
9[8]KNOWLES J W, ESPOSITO G, MAO L, et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor a-deficient mice [J].J Clin Invest, 2001,107(8): 975-984.
10[9]BROCKHOFF C, WARNHOLTZ A, MUNZEL T.Atrial natriuretic peptides: diagnostic and therapeutic potential [J]. Ther Umsch, 2000,57(5):305-312.
9Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension[J]. J Am Coil Cardiol, 1992,19(7):1550-1558.
10Milani RV, Lavie CJ, Mehra MR, et al. Left vertricular geometry and survival in patients with normal left vertricular ejection fraction[J]. Am J Cardiol, 2006,97 (7) :959-963.
